Eric Ankerud Net Worth & Insider Trades

Eric Ankerud - See Remarks, Ocular Therapeutix, Inc

As of February 10, 2017

What is Eric Ankerud's Net Worth?

The current estimated net worth of Ocular Therapeutix, Inc's See Remarks, Eric Ankerud, is estimated to be about $297.3K . Eric Ankerud owns about 78,651 units of Ocular Therapeutix, Inc common stock. In the last 2 years at Ocular Therapeutix, Inc, Eric Ankerud has sold an estimated value of $0 worth.

What is Eric Ankerud's Past Insider Trading?

Eric Ankerud's largest purchase order was 1,000 units , worth over $13K on March 6, 2015. In total, Eric Ankerud has made about 4 transactions over 2 years of their time at Ocular Therapeutix, Inc. Eric Ankerud usually trades in February, with the busiest year in 2015.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Eric Ankerud's' Mailing Address?

  • Mailing address is C/o Ocular Therapeutix, Inc. 36 Crosby Dr., Suite 101 Bedford MA 01730 MA

Ocular Therapeutix, Inc Executive Compensation

Name
Year
Salary
Total
Antony Mattessich 2020 $600,000 $2,163,150
Antony Mattessich 2019 $581,796 $2,126,146
Michael Goldstein, M.D. 2020 $440,000 $1,336,250
Michael Goldstein, M.D. 2019 $423,906 $1,007,731
Philip C. Strassburger, Esq. 2020 $125,592 $2,413,764
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1393434/000155837021005257/tmb-20210618xdef14a.htm

What are Ocular Therapeutix, Inc's Past Insider Trades?

Ocular Therapeutix, Inc's most recent insider trade came on September 29, 2022 by Summer Road Llc who bought 150,000 units worth $689.23K . In the last 8 years, insiders at Ocular Therapeutix, Inc have sold an estimated value of $72.54M and bought an estimated value of $27.21M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Amarpreet Sawhney, Chairman the Board,  Charles M Warden, Director,  and Richard L. Lindstrom, M.D., Director .

OCULAR THERAPEUTIX, INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1